Study: Pediatric Readmission Rate 2X Higher After Stem Cell Transplant From Donor

Listen
Text
  • Small
  • Medium
  • Large
Pediatric patients who received a stem cell transplant using donated stem cells had a readmission rate twice that of patients who received their own cells, according to a study that will be presented at the American Society of Pediatric Hematology/Oncology annual meeting.

The records of 129 pediatric patients who received a stem cell transplant between 2008 and 2011 were reviewed. Of these patients, 64 percent were readmitted within 180 days of the procedure.


The source of the transplanted cells was found to be linked to readmission rates— of the patients who received cells from a donor, 79 percent were readmitted at least once within six months. Of those who received their own cells, 38 percent were readmitted.

More Articles on Pediatric Quality:

Children's of Alabama Reduces Chemotherapy Medication Errors by 50%
Study: Fast Tracking Pediatric Congenital Heart Surgery Patients Saves Time, Money
NIST Panel Expands Recommendations to Promote Pediatric EHR Adoption

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars